Device Trial Radar · NCT04663867
AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
Feb 3, 2021
Primary completion
Apr 25, 2023
Study completion Jun 15, 2023
Sponsor
- Lead sponsor
- AngioSafe, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Veranex, Inc.
- First posted
- Dec 11, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to evaluate the safety and efficacy of the AngioSafe Peripheral CTO Crossing System.
Conditions
- Peripheral Artery Occlusion
- Peripheral Arterial Disease
Interventions
AngioSafe Peripheral CTO Crossing SystemDevice
The AngioSafe Peripheral CTO Crossing System is intended to facilitate the intraluminal placement of guidewires beyond stenotic lesions, including chronic total occlusions (CTOs) in the peripheral vasculature.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Success of AngioSafe Peripheral CTO Crossing SystemTime frame: 24 Hours
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Dignity Health - Chandler Regional Medical Center
Chandler, Arizona
Adventist Health St. Helena
St. Helena, California
Vascular Care Connecticut
Darien, Connecticut
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.